Value Proposition of FDA-Approved Artificial Intelligence Algorithms for Neuroimaging

Suryansh Bajaj1, Mihir Khunte1, Nagaraj S Moily2

  • 1Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.

Summary

Artificial intelligence (AI) in neuroimaging has seen significant growth, with most developers claiming improved patient care. However, clinical validation of these AI algorithms is still needed.